Genes, Genetics, and Environment in Type 2 Diabetes: Implication in Personalized Medicine

DNA and Cell Biology

Volumn 35, Issue 1, 2016, Pages 1-12

  Kaul, Nabodita ^a   Ali, Sher ^a,b  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; INSULIN;

DISEASE ASSOCIATION; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; EPIGENETICS; ETHNICITY; GENE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENETICS; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATIENT CARE; PERSONALIZED MEDICINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SECRETORY PATHWAY; SIGNAL TRANSDUCTION; ANIMAL; DIABETES MELLITUS, TYPE 2; ENVIRONMENT; GENETIC ASSOCIATION STUDY; METABOLISM; PROCEDURES; SECRETION (PROCESS); TRENDS;

ANIMALS; DIABETES MELLITUS, TYPE 2; ENVIRONMENT; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; HUMANS; INSULIN; METABOLIC NETWORKS AND PATHWAYS; PRECISION MEDICINE;

EID: 84954192759     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2015.2883     Document Type: Review

References (87)

1. Alharbi, K.K., Khan, I.A., et al. (2014). Association of the genetic variants of insulin receptor substrate 1 (IRS-1) with type 2 diabetes mellitus in a Saudi population. Endocrine 47, 472-477.
2. American Diabetes Association. (2011). Diagnosis and classification of diabetes mellitus. Diabetes Care 29, S43-S48.
3. Arner, P. (1997). Regional adipocity in man. J Endocrinol 155, 191-192.
4. Aulchenko, Y.S., Pullen, J., et al. (2007). LPIN2 is associated with type 2 diabetes, glucose metabolism, body composition. Diabetes 56, 3020-3026.
5. Barres, R., Osler, M.E., et al. (2009). Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab 10, 189-198.
6. Brons, C., Jacobsen, S., et al. (2010). Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weightdependent manner. J Clin Endocrinol Metab 95, 3048-3056.
7. Cai, Y., Yi, J., Ma, Y., Fu, D. (2011). Meta-analysis of the effect of HHEX gene polymorphism on the risk of type 2 diabetes. Mutagenesis 26, 309-314.
8. Canivell, S., Ruano, E.G., et al. (2014). Differential methylation of TCF7L2 promoter in peripheral blood DNA in newly diagnosed, drug-naive patients with type 2 diabetes. PLoS One 9, e99310.
9. Carlson, C.S., Aldred S.F, et al. (2005). Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 77, 64-77.
10. Cheyssac, C., Lecoeur, C., et al. (2006). Analysis of common PTPN1 gene variants in type 2 diabetes, obesity and associated phenotypes in the French population. BMC Med Genet 7, 44.
11. Chu, W.S., Das, S.K., et al. (2007). Activating transcription factor 6 (ATF6) sequence polymorphisms in type 2 diabetes and pre-diabetic traits. Diabetes 56, 856-862.
12. Crispim, D., Fagundes, N.J., et al. (2010). Polymorphisms of the UCP2 gene are associated with proliferative diabetic retinopathy in patients with diabetes mellitus. Clin Endocrinol (Oxf) 72, 612-619.
13. Daimon, M., Sato, H., et al. (2008). Salt consumptiondependent association of the GNB3 gene polymorphism with type 2 DM. Biochem Biophys Res Commun 374, 576-580.
14. de Lorenzo, C., Greco, A., et al. (2013). Variants of insulinsignaling inhibitor genes in type 2 diabetes and related metabolic abnormalities. Int J Genomics 2013, 376-454.
15. Du, B., Liu, S., et al. (2013). Association between glucose transporter 1 rs841853 polymorphism and type 2 diabetes mellitus risk may be population specific (1rs8418532). J Diabetes 5, 291-299.
16. Fisher, E., Schreiber, S., et al. (2011). A two-step association study identifies CAV2 rs2270188 single nucleotide polymorphism interaction with fat intake in type 2 diabetes risk. J Nutr 141, 177-181.
17. Foucan, L., Maimaitiming, S., et al. (2014). Adiponectin gene variants, adiponectin isoforms and cardiometabolic risk in type 2 diabetic patients. J Diabetes Investig 5, 192-198.
18. Franks, P.W., Christophi, C.A., et al. (2014). Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program. Diabetologia 57, 485-490.
19. Fu, M., Damcott, C.M., et al. (2004). Polymorphism in the calsequestrin 1 (CASQ1) gene on chromosome 1q21 is associated with type 2 diabetes in the old order Amish. Diabetes 53, 3292-3299.
20. Gaens, K.H., van Der Kallen, C.J., et al. (2008). Receptor for advanced glycation end product polymorphisms and type 2 diabetes: the CODAM study. Ann N Y Acad Sci 1126, 162-165.
21. Gallagher, C.J., Keene, K.L., et al. (2007). Investigation of the estrogen receptor-alpha gene with type 2 diabetes and/or nephropathy in African-American and European-American populations. Diabetes 56, 675-684.
22. Gandhi, K., Adhikari, P., Basu, A., Achappa, B. (2013). Association between a 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphism and metabolic syndrome in a South Indian population. Metab Syndr Relat Disord 11, 397-402.
23. Gilbert, E.R., Liu, D. (2012). Epigenetics: the missing link to understanding beta-cell dysfunction in the pathogenesis of type 2 diabetes. Epigenetics 7, 841-852.
24. Grarup, N., Stender-Petersen, K.L., et al. (2008). Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, insulin resistance: a study of 15,734 Danish subjects. Diabetes 57, 1136-1142.
25. Guyton, C., Hall, J.E. (2010). Text Book of Medical Physiology: Insulin, Glucagon and Diabetes Mellitus, 11th ed. (Saunders, Elsevier, Philadelphia), pp. 939-950.
26. Haghverdizadeh, P., Sadat Haerian, M., Sadat Haerian, B. (2014). ABCC8 genetic variants and risk of diabetes mellitus. Gene 545, 198-204.
27. Harding, A.H., Loos, R.J., et al. (2006). Polymorphisms in the gene encoding sterol regulatory element-binding factor-1c are associated with type 2 diabetes. Diabetologia 49, 2642-2648.
28. Heijmans, B.T., Tobi, E.W., et al. (2008). Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 105, 17046-17049.
29. Holmkvist, J., Almgren, P., et al. (2005). Haplotype construction of the FRDA gene and evaluation of its role in type II diabetes. Eur J Hum Genet 13, 849-855.
30. Horikoshi, M., Hara, K., et al. (2006). A polymorphism in the AMPKalpha2 subunit gene is associated with insulin resistance and type 2 diabetes in the Japanese population. Diabetes 55, 919-923.
31. Hu, F.B. (2011). Globalization of diabetes-the role of diet, lifestyle, gene. Diabetes Care 34, 1249-1257.
32. Jia, Z., Zhang, X., Kang, S., Wu, Y. (2013). Association of endothelial nitric oxide synthase gene polymorphisms with type 2 diabetes mellitus: a meta-analysis. Endocr J 60, 893-901.
33. Karamohamed, S., Demissie, S., et al. (2003). Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes 52, 1562-1567.
34. Kaul, N., Singh, Y.P., Bhanwer, A.J.S. (2015). Influence of ethnicity in association of WC, WHR, hypertension and PGC-1a (Gly482Ser), UCP2-866 G/A and SIRT1-1400 T/C polymorphisms with T2D in population of Punjab. Gene 563, 150-154.
35. Keshavarz, P., Inoue, H., et al. (2008). Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK alpha2-subunit (PRKAA2) and risk of type 2 diabetes. Mol Genet Metab 93, 200-209.
36. Kifagi, C., Makni, K., et al. (2011). Association of genetic variations in TCF7L2, SLC30A8, HHEX, LOC387761, EXT2 with Type 2 diabetes mellitus in Tunisia. Genet Test Mol Biomarkers 15, 399-405.
37. Kilpelainen, T.O., Lakka, T.A., et al. (2007). Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes. Physiol Genomics 31, 264-272.
38. Klimentidis, Y.C., Lemas, D.J., et al. (2014). CDKAL1 and HHEX are associated with type 2 diabetes-related traits among Yup'ik people. J Diabetes 6, 251-259.
39. Konheim, Y.L., Wolford, J.K. (2003). Association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians. Hum Genet 113, 377-381.
40. Langberg, E.C., Gu, H.F., et al. (2007). Genetic variation in receptor protein tyrosine phosphatase sigma is associated with type 2 diabetes in Swedish Caucasians. Eur J Endocrinol 157, 459-464.
41. Lear, S.A., Chen, M.M., et al. (2002). The relationship between waist circumference and metabolic risk factors: cohorts of European and Chinese descent. Metabolism 51, 1427-1432.
42. Lear, S.A., Humphries, K.H., et al. (2007). Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr 86, 353-359.
43. Li, T., Shi, Y., Yin, J., et al. (2014). The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis. Int Urol Nephrol 47, 117-130.
44. Li, Y.F., Sun, H.X., et al. (2003). Protein kinase C/zeta (PRKCZ) gene is associated with type 2 diabetes in Han population of North China and analysis of its haplotypes. World J Gastroenterol 9, 2078-2082.
45. Lim, J.H., Ko, M., et al. (2012). Differential association of uncoupling protein 2 polymorphisms with pattern identification among korean stroke patients: a diagnostic system in traditional Korean medicine. Evid Based Complement Alternate Med 2012, 532078.
46. Liu, J.X., Liu, J., et al. (2012). Association of sterol regulatory element binding protein-1c genetic polymorphisms rs2297508 and rs11868035 with type 2 diabetes mellitus in Gansu Han and Dongxiang population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 29, 328-333.
47. Liu, L., Yang, X., et al. (2013). Association between variants of EXT2 and type 2 diabetes: a replication and meta-analysis. Hum Genet 132, 139-145.
48. Liu, Y., Niu, N., et al. (2008). Genetic variation and association analyses of the nuclear respiratory factor 1 (nRF1) gene in Chinese patients with type 2 diabetes. Diabetes 57, 777-782.
49. Lowell, B.B., Shulman, G.I. (2005). Mitochondrial dysfunction and type 2 diabetes. Science 307, 384-387.
50. Mahajan, A., Tabassum, R., et al. (2010). Obesity-dependent association of TNF-LTA locus with type 2 diabetes in North Indians. J Mol Med (Berl) 88, 515-522.
51. Meng, J., Li, N.F., et al. (2014). Relationship between female dyslipidemia and polymorphism of suppressor of cytokine signaling-3 in Xinjiang Uygur population. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 36, 5-11.
52. Mita, M., Miyake, K., et al. (2008). Association study of the effect of WFS1 polymorphisms on risk of type 2 diabetes in Japanese population. Kobe J Med Sci 54, E192-E199.
53. Mohammed, S., Dasgupta, S., et al. (2015). MTNR1B gene polymorphisms and susceptibility to type 2 diabetes: a pilot study in South India. Gene 566, 189-193.
54. Moritani, M., Nomura, K., et al. (2007). Genetic association of single nucleotide polymorphisms in endonuclease G-like 1 gene with type 2 diabetes in a Japanese population. Diabetologia 50, 1218-1227.
55. Murcray, C.E., Lewinger, J.P., Gauderman, W.J. (2008). Gene-environment interaction in genome wide association studies. Am J Epidemiol 169, 219-226.
56. Neel, J.V. (1962). Diabetes mellitus: a "Thrifty" genotype rendered detrimental by "Progress" Am J Hum Genet 14, 353-362.
57. Nitz, I., Fisher, E., et al. (2007). Association of prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism with type 2 diabetes in two German study populations. J Clin Endocrinol Metab 92, 3183-3188.
58. Omori, S., Tanaka, Y., et al. (2008). Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 57, 791-795.
59. Peng, F., Hu, D., et al. (2013). The relationship between five widely-evaluated variants in CDKN2A/B and CDKAL1 genes and the risk of type 2 diabetes: a meta-analysis. Gene 531, 435-443.
60. Porter, J.R., Barrett, T.G. (2005). Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and beta cell failure. J Med Genet 42, 893-902.
61. Pradas-Juni, M., Nicod, N., et al. (2014). Differential transcriptional and posttranslational transcription factor 7-like regulation among nondiabetic individuals and type 2 diabetic patients. Mol Endocrinol 28, 1558-1570.
62. Qi, L., Hu, F.B., Hu, F.B. (2008). Genes, environment, interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes. Curr Mol Med 8, 519-532.
63. Qi, L., Rifai, N., Hu, F.B. (2007). Interleukin-6 receptor gene variations, plasma interleukin-6 levels, type 2 diabetes in U.S. Women. Diabetes 56, 3075-3081.
64. Qin, L.J., Lv, Y., Huang, Q.Y. (2013). Meta-analysis of association of common variants in the KCNJ11-ABCC8 region with type 2 diabetes. Genet Mol Res 12, 2990-3002.
65. Rampersaud, E., Damcott, C.M., Fu, M., et al. (2007). Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations. Diabetes 56, 3053-3062.
66. Raz, I., Eldor, R., et al. (2005). Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes Metab Res Rev 21, 3-14.
67. Rees, S.D., Britten, A.C., et al. (2009). The promoter polymorphism-232C/G of the PCK1 gene is associated with type 2 diabetes in a UK-resident South Asian population. BMC Med Genet 10, 83.
68. Ren, J., Xiang, A.H., et al. (2014). Genetic variation in MTNR1B is associated with gestational diabetes mellitus and contributes only to the absolute level of beta cell compensation in Mexican Americans. Diabetologia 57, 1391-1399.
69. Rudovich, N., Pivovarova, O., et al. (2009). Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes. J Mol Med (Berl) 87, 1145-1151.
70. Rutter, G.A., Chimienti, F. (2014). SLC30A8 mutations in type 2 diabetes. Diabetologia 57, 485-490.
71. Saif-Ali, R., Harun, R., et al. (2011). Hepatocyte nuclear factor 4 alpha P2 promoter variants associate with insulin resistance. Acta Biochim Pol 58, 179-186.
72. Salopuro, T., Pulkkinen, L., et al. (2009). Variation in the UCP2 and UCP3 genes associates with abdominal obesity and serum lipids: the Finnish Diabetes Prevention Study. BMC Med Genet 10, 94.
73. Salpea, K.D., Gable, D.R., et al. (2009). The effect of WNT5B IVS3C>G on the susceptibility to type 2 diabetes in UK Caucasian subjects. Nutr Metab Cardiovasc Dis 19, 140-145.
74. Saxena, M., Agrawal, C.G., et al. (2014). Interleukin-6 (IL-6)-597 A/G (rs1800797) &-174 G/C (rs1800795) gene polymorphisms in type 2 diabetes. Indian J Med Res 140, 60-68.
75. Sharma, R., Matharoo, K., et al. (2013). Ethnic differences in CAPN10 SNP-19 in type 2 diabetes: a North-West Indian case control study and evidence from meta-analysis. Genet Res (Camb) 95, 146-155.
76. Sun, X., Yu, W., Hu, C. (2014). Genetics of type 2 diabetes: insights into the pathogenesis and its clinical application. Biomed Res Int 2014, 926713.
77. Tabassum, R., Chauhan, G., et al. (2013). Genome-wide association study for type 2 diabetes in Indians identifies a new susceptibility locus at 2q21. Diabetes 62, 977-986.
78. Tellechea, M.L., Muzzio, D.O., et al. (2013). Association between beta2-adrenoceptor (ADRB2) haplotypes and insulin resistance in PCOS. Clin Endocrinol (Oxf) 78, 600-606.
79. Trombetta, M., Bonetti, S., et al. (2012). CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. The Verona newly diagnosed type 2 diabetes study (VNDS) 3. PLoS One 7, e32755.
80. Wang, H., Liu, L., et al. (2013). Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk. PLoS One 8, e67665.
81. Weedon, M.N., Clark, V.J., et al. (2006). A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses. Am J Hum Genet 79, 991-1001.
82. Wijesekara, N., Chimienti, F., Wheeler, M.B. (2009). Zinc, a regulator of islet function and glucose homeostasis. Diabetes Obes Metab 11, 202-214.
83. Wren, J.D., Garner, H.R. (2005). Data-mining analysis suggests an epigenetic pathogenesis for type 2 diabetes. J Biomed Biotechnol 2005, 104-112.
84. Xu, H.X., Xu, W., et al. (2013). Association of TNF-1031T/C and clinical efficacy of insulin therapy in newly diagnosed type 2 diabetics. Zhonghua Yi Xue Za Zhi 93, 3197-3201.
85. Yang, B.T., Dayeh, T.A., et al. (2012). Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol Endocrinol 26, 1203-1212.
86. Zee, R.Y., Germer, S., et al. (2008). C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study. Atherosclerosis 197, 931-936.
87. Zheng, C., Dalla Man, C., et al. (2015). A common variant in the MTNR1b gene is associated with increased risk of impaired fasting glucose (IFG) in youth with obesity. Obesity (Silver Spring) 23, 1022-1029.